Bevacizumab in age ‐related macular degeneration: a randomized controlled trial on the effect of on‐demand therapy every 4 or 8 weeks

Acta Ophthalmologica, EarlyView.

Source: Acta Ophthalmologica - October 28, 2018 Category: Opthalmology Authors: Sankha Amarakoon, Jos é P. Martinez‐Ciriano, L. Ingeborgh Born, Seerp Baarsma, Tom Missotten Source Type: research